This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yangtze River Pharmaceutical Group Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Lingwu Chen: Innovator in Pharmaceutical Science
Introduction
Lingwu Chen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical science, particularly through his innovative work on yonkenafil hydrochloride.
Latest Patents
Lingwu Chen holds a patent for a polymorphic substance of yonkenafil hydrochloride, along with its preparation method, composition, and use. The patent describes an A-type polymorphic substance characterized by a specific powder diffraction pattern. This pattern includes diffraction peaks at various 2θ values, such as 8.4±0.2°, 11.3±0.2°, and 14.2±0.2°, among others. His work in this area is crucial for advancing pharmaceutical formulations and applications.
Career Highlights
Lingwu Chen is associated with the Yangtze River Pharmaceutical Group Co., Ltd., where he has been instrumental in research and development. His expertise in polymorphic substances has positioned him as a key figure in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Haibo Zhang and Xianfeng Lu, to further enhance the research and development efforts within his organization.
Conclusion
Lingwu Chen's contributions to the field of pharmaceutical science, particularly through his patent on yonkenafil hydrochloride, highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile